Dollars for Docs: Talk With Your Doctor

https://projects.propublica.org/docdollars/
You can print this page and show it to your doctor.

This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.

ProPublica's Dollars for Docs database lets you search for payments to U.S.-based doctors made by pharmaceutical and medical device companies between August 2013 and December 2018. The disclosure of these payments is required under the Physician Payments Sunshine Act, a provision of the 2010 Affordable Care Act.

About This Information

  • The information that appears here comes directly from the federal government. Companies must attest to its accuracy, and doctors have the ability to contest information they believe is in error.
  • This site includes payments for such activities as speaking, consulting, meals, travel and royalties. It does not include payments for clinical research.
  • It is legal for companies to make payments to doctors as long as the payments are not a kickback or inducement to use their products.
  • Some doctors say collaborative relationships, particularly those involving research, are necessary to develop new treatments and cures. But many ethicists have raised questions about the payments, and studies show that they may influence doctors' prescribing decisions.
  • Only you can decide if this matters to you and if so, whether you want to talk with your doctor about it. If you plan to talk with your doctor (or if you already have), please help us by filling out this short survey: propub.li/participate-d4d

Preparing for Your Conversation

If you decide you'd like to talk to your doctor about this, please keep in mind:

  • Many health care professionals in our database have similar names, so you should start by asking your doctor if the person mentioned in this payment record is really him/her.
  • Your doctor may not know he or she is listed as receiving payments, especially if the payments are small. You can direct your doctor to this site (the URL will be printed at the top of the payment record) or directly to the government's site here: https://openpaymentsdata.cms.gov/physician/140998
  • Some doctors are happy to discuss this information with you. Others might not be. The best approach is to ask questions and to not be accusatory.

Questions You Might Want to Ask

  • Is this you?
  • What type of work do you do with these companies?
  • Have you prescribed me any drugs that are manufactured by companies you've taken payments from?
  • Are there non-drug alternatives that I may want to consider first?
  • Are there less expensive generic alternatives to the drugs you have prescribed?
  • What devices have you used in my care that are manufactured by companies you've taken payments from?

Dollars for Docs: Talk With Your Doctor

https://projects.propublica.org/docdollars/doctors/pid/140998
If you spot an error, please let us know at [email protected].

This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.

NEAL OSBORN

Listed Specialty: Gastroenterology
8855 HOSPITAL DR, SUITE 101, DOUGLASVILLE, GA, 30134-2267

2018 Payments: At a Glance

283

payments

$135,018

payment total

22

companies paid this doctor

Types of Payments

Category Payments Payment Value
Nonaccredited Training
 14 $55,100
Promotional Speaking/Other
 22 $43,250
Travel and Lodging
 57 $23,002
Consulting
 2 $7,650
Food and Beverage
 187 $6,002
Education
 1 $15

Drugs & Devices in 2018

Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.

Product Name Product Type Payments†
XIFAXAN

drug

 $31,095
STELARA

drug

 $27,958
UCERIS

drug

 $26,743
REMICADE

drug

 $22,775
Payments with no listed product

N/A

 $21,113
XELJANZ

drug

 $8,289
RELISTOR

drug

 $6,921
LINZESS

drug

 $6,674
VIBERZI

drug

 $6,466
HUMIRA

drug

 $4,298
TRULANCE

drug

 $483
CIMZIA

drug

 $162
SUCRAID

drug

 $104
AMITIZA

drug

 $67
ENTYVIO

drug

 $66
INJECTAFER

drug

 $62
CANASA

drug

 $60
ZEPATIER

drug

 $44
CLENPIQ

drug

 $40
SUPREP

drug

 $36
† May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products.

For ease of printing, only the 20 drugs and devices with the highest payments are displayed. For a complete list, please visit: https://projects.propublica.org/docdollars/doctors/pid/140998

Payment Details

When How Much Related To What For From Third Party Payee
Jun 2, 2018 $5,250 No Listed Product Consulting US WORLDMEDS, LLC
Feb 1, 2018 $4,300 XIFAXAN Nonaccredited Training SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC
Mar 2, 2018 $4,300 XIFAXAN Nonaccredited Training SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC
Mar 13, 2018 $4,300 XIFAXAN Nonaccredited Training SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC
May 22, 2018 $4,300 UCERIS Nonaccredited Training SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC
May 11, 2018 $4,300 UCERIS Nonaccredited Training SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC
Jul 2, 2018 $4,300 UCERIS Nonaccredited Training SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC
Dec 10, 2018 $4,300 XIFAXAN Nonaccredited Training SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC
May 11, 2018 $4,300 UCERIS Nonaccredited Training SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC
Jun 22, 2018 $4,300 UCERIS Nonaccredited Training SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC
Mar 16, 2018 $4,300 XIFAXAN Nonaccredited Training SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC
Jan 23, 2018 $4,300 RELISTOR Nonaccredited Training SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC
Jun 14, 2018 $3,500 STELARA REMICADE Promotional Speaking/Other JANSSEN SCIENTIFIC AFFAIRS, LLC
Feb 18, 2018 $3,500 STELARA Promotional Speaking/Other JANSSEN SCIENTIFIC AFFAIRS, LLC
Apr 17, 2018 $3,500 STELARA REMICADE Promotional Speaking/Other JANSSEN SCIENTIFIC AFFAIRS, LLC
Apr 12, 2018 $3,500 STELARA REMICADE Promotional Speaking/Other JANSSEN SCIENTIFIC AFFAIRS, LLC
Apr 12, 2018 $3,500 STELARA REMICADE Promotional Speaking/Other JANSSEN SCIENTIFIC AFFAIRS, LLC
Sep 4, 2018 $3,150 No Listed Product Promotional Speaking/Other ABBVIE, INC.
Jul 30, 2018 $3,000 XIFAXAN Nonaccredited Training SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC
Apr 27, 2018 $2,400 No Listed Product Consulting SALIX PHARMACEUTICALS, A DIVISION OF BAUSCH HEALTH US, LLC

For ease of printing, 20 payments are displayed, the largest appearing on top. For a full list of payments, please visit: https://projects.propublica.org/docdollars/doctors/pid/140998

Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].

This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.